The guidance on Requests for Feedback
on Medical Device Submissions (Pre-Submissions Program) establishes
a structured process for submission and management of
Pre-Submissions and supports the procedures that CDRH and CBER
intend to follow when manufacturers, their representatives, or
application sponsors submit a request for feedback on a medical
device submission, including when the preferred method of feedback
is a meeting with review staff. The guidance also provides
recommendations regarding how to prepare for meetings with FDA
staff. These voluntary information collection requirements support
a structured process with clear recommendations for sponsors who
submit a pre-submission feedback request and for FDA staff and
managers involved in their review, as well as expected timeframes
for scheduling meetings.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.